SUDHIN BIOPHARMA CO.
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 17 Oct 2023)
What this means for you
Registered since 25 Apr 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 25 Apr 2027, and its filing window is open now).
Record
- Serial number
- 86359502
- Registration number
- 5191596
- Mark type
- Design + words
- Filed
- 06 Aug 2014
- Published for opposition
- 20 Jan 2015
- Registered
- 25 Apr 2017
- Next maintenance filing
- §8 & §9 renewal, due by 25 Apr 2027 (grace period to 25 Oct 2027)
- Attorney of record
- Jeanette E. Sinclare
Goods and services
- Class 042 — Scientific and technological services: Biotechnology research and development; biopharmaceutical research and development; consultation in the fields of biotechnology and biopharmaceuticals
Owner
- Sudhin Biopharma Company, Superior, CO, US
- Sudhin Biopharma Company, Superior, CO, US
- Sudhin Biopharma Company, Superior, CO, US
Prosecution history
- 25 Apr 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 Nov 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Oct 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Oct 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Apr 2023 — TEAS SECTION 8 & 15 RECEIVED
- 25 Apr 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Apr 2017 — REGISTERED-PRINCIPAL REGISTER
- 18 Mar 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Mar 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Feb 2017 — USE AMENDMENT FILED